regulatory status raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; may appear as cake |
| Solubility class | Water-soluble | Often reconstituted in aqueous buffer |
| Typical storage temperature | −20 °C or below | Protect from light and moisture |
| Typical analytical method | RP-HPLC and mass spectrometry | Used for purity and identity |
| Common synonyms | AOD-9604; AOD9604; hGH fragment 176-191 | Research name and fragment description |
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
== Cause == Yaws is caused by infection with bacteria of the Treponema pallidum subspecies pertenue. The initial yaws wound contains infectious bacteria, which are passed onto others through skin-to-skin contact, typically during play or other normal childhood interactions. Early (primary and secondary) yaws lesions have a higher bacterial load, thus are more infectious. Both papillomas and ulcers are infectious. Infectivity is thought to last 12–18 months after infection, longer if a relapse occurs. Early yaws lesions are often itchy, and more lesions may form along lines that are scratched. Yaws may be evolving into less conspicuous lesions. After a new person is infected, an infectious papilloma will form within 9–90 days (on average 21 days). T. pallidum pertenue has been identified in nonhuman primates (baboons, chimpanzees, and gorillas) and experimental inoculation of human beings with a simian isolate causes yaws-like disease. However, no evidence exists of cross-transmission between human beings and other primates, but more research is needed to discount the possibility of a yaws animal reservoir in nonhuman primates.
== Education == Sherman received his bachelor's degree in biology in 1947 from Brown University. In 1949 he received a master's degree in biology from Western Reserve University (now Case Western University). He completed his graduate studies at the University of Iowa, where he earned a doctorate in zoology in 1954. Sherman's doctoral thesis and research activity initially focused on electron microscopy, and later freezing kidney tissue; but he ultimately changed his subject to freezing and freeze-drying human semen after a series of successful trials in the university's urology department and fertility clinic.
== External links == Diabetes in America, 2nd Edition (textbook) (PDFs) Archived 25 April 2011 at the Wayback Machine – National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) IDF Diabetes Atlas Type 1 Diabetes Archived 30 October 2009 at the Wayback Machine at the American Diabetes Association ADA's Standards of Medical Care in Diabetes 2019
== Uses == The plant is used in the traditional medicine of Indonesia, Malaysia and Vietnam where the root of the plant is boiled in water, and the water is consumed as a tonic. The flower and fruits are used to treat dysentery, and the root is used for malaria, fever, and other ailments.
Sources: en.wikipedia.org
De novo nucleation by the Arp2/3 complex, formins, and Spire that forms a trimer Barbed-end uncapping by the removal of barbed-end-capping proteins (CapZ, Hsp70, EPS8) Barbed-end uncapping by actin-binding-proteins that sever actin filaments Elongation Facilitated in vivo by polymerization promoters and barbed-end capping inhibitory proteins. The elongation phase begins when the concentration of short, F-actin polymers is significantly larger than at equilibrium. At this point, both termini accept the addition of new monomers (although primarily at the "barbed end") and the actin microfilament lengthens. Termination Involves the degradation of polyphosphoinositides and reactivation of "barbed end" capping proteins Hsp70 and CapZ, thereby reinitiating barbed-end capping and greatly diminishing elongation. Despite the presence of active capping proteins, certain inhibitors including profilin, formins, ENA and VASP promote elongation. These inhibitors may function in a variety of different methods, however, most employ the inhibition of subunit depolymerization and actin-depolymerizing actin-binding-proteins. Branching amplification Consists of the nucleation of new actin microfilaments from the existing sides of F-actin. The cell employs Arp2/3 complex to temporarily bind to existing polymers at a 70° angle. The Arp2/3 complex then elongates into a filamentous branch that proves essential for intracellular reorganization through cytoskeletal changes.
=== Peripheral half-life === Some substances may have different half-lives in different parts of the body. For example, oxytocin has a half-life of typically about three minutes in the blood when given intravenously. Peripherally administered (e.g. intravenous) peptides like oxytocin cross the blood-brain-barrier very poorly, although very small amounts (< 1%) do appear to enter the central nervous system in humans when given via this route. In contrast to peripheral administration, when administered intranasally via a nasal spray, oxytocin reliably crosses the blood–brain barrier and exhibits psychoactive effects in humans. In addition, unlike the case of peripheral administration, intranasal oxytocin has a central duration of at least 2.25 hours and as long as 4 hours. In likely relation to this fact, endogenous oxytocin concentrations in the brain have been found to be as much as 1000-fold higher than peripheral levels.
In chemistry, orthogonality is when two or more protecting groups in a chemical compound can be removed under conditions that do not affect the other(s). Two such protecting groups are said to be orthogonal. A classic example is the Fmoc group which requires base to be removed, and the Boc group which requires acid; treatment with base will not affect the Boc groups, and treatment with acid will not affect the Fmoc groups. Orthogonal protection is widely used in organic chemistry and synthetic chemistry to allow chemists to perform multiple transformations on complex molecules while controlling the order in which functional groups are revealed.
== Society and culture == In the US, fillers are approved as medical devices by the Food and Drug Administration (FDA) and the injection is prescribed and performed by a provider. What defines a qualified dermal injection provider varies by country and is a point of debate between board-certified doctors and injectors who operate under cosmetic or aesthetician licenses. Fillers are not to be confused with neurotoxins such as Botox. Fillers are not approved for certain parts of the body where they can be unsafe, including the penis. In the European Economic Area and the UK, fillers are non-prescription medical devices that can be injected by anyone licensed to do so by the respective medical authorities. They require a CE mark, which regulates adherence to production standards, but does not require any demonstration of medical efficacy. As a result, there are over 140 injectable fillers in the UK/European market and only six approved for use in the US. In China, the NMPA (formerly CFDA) has also issued guidance to regulate injectable fillers.
Robert William Barker was born on December 12, 1923, in Darrington, Washington, and spent most of his youth on the Rosebud Indian Reservation in Mission, South Dakota. The U.S. Indian Census Rolls, 1885–1940, list Barker as a citizen of the Rosebud Sioux Tribe, which the tribe publicly confirmed. His mother, Matilda ("Tillie") Valandra (née Matilda Kent Tarleton), was a schoolteacher; his father, Byron John Barker, was the foreman on the electrical high line through the state of Washington. Barker's father was one-quarter Sicangu, and his mother non-Native, thus Barker was one-eighth Sicangu. Barker once said, "I've always bragged about being part Indian, because they are a people to be proud of. And the Sioux were the greatest warriors of them all." He attended grade school on the Rosebud Reservation where his mother was a teacher. Barker met his future wife, Dorothy Jo Gideon, at an Ella Fitzgerald concert while he was attending high school in Missouri; they began dating when he was 15. Barker attended Drury College (now Drury University) in Springfield, Missouri, on a basketball athletic scholarship. He was a member of the Epsilon Beta chapter of Sigma Nu fraternity at Drury. Barker joined the United States Navy Reserve in 1943 during World War II to train as a fighter pilot but did not serve in combat. On January 12, 1945, while on leave from the military, Barker married Dorothy Jo. After the war, he returned to Drury to finish his education, graduating summa cum laude with a degree in economics.
Sources: en.wikipedia.org
== External links == Information Digest, 2022–2023 (NUREG-1350, Volume 34), NRC Reactors Designed by Argonne National Laboratory: Fast Reactor Technology Argonne pioneered the development of fast reactors and is a leader in the development of fast reactors worldwide. See also Argonne's Nuclear Science and Technology Legacy. The Changing Need for a Breeder Reactor by Richard Wilson at The Uranium Institute 24th Annual Symposium, September 1999 Experimental Breeder Reactor-II (EBR-II): An Integrated Experimental Fast Reactor Nuclear Power Station International Thorium Energy Organisation – www.IThEO.org A Path Forward for the LMFBR Plutonium Fuel Fabrication by Argonne National Laboratory on YouTube
== Academics and science == Mark C. Alexander, law professor at Seton Hall University Buzz Aldrin (born 1930), astronaut, who was the second man to walk on the Moon Virginia Lee Block (1902–1970), psychologist who contributed to studies regarding child and adolescent psychology Stella Stevens Bradford (1871–1959), doctor, specialist in tuberculosis and physical rehabilitation H. Bruce Franklin (1934–2024), author and historian who was expelled from his Stanford University professorship for involvement in a leftist group Tom Galligan (born 1955), lawyer, legal scholar, administrator, and educator who is currently the dean and professor of law of Louisiana State University's Paul M. Hebert Law Center Dean Hamer (born 1952), scientist, author, and filmmaker who discovered a link between sexual orientation and Xq28 Jordan Harrod (born 1996), research scientist and YouTuber who works on neuroengineering, brain-machine interfaces, and machine learning for medicine George Rice Hovey (1860–1943), university president, professor, minister, and author who served as the president of Virginia Union University from 1904 to 1918 John A. Kenney Jr. (1914–2003), pioneering African-American dermatologist who specialized in the study of skin disorders affecting racial minorities, earning him recognition as the "dean of black dermatology" Joshua Lederberg (1925–2008), geneticist who received the 1958 Nobel Prize in Physiology or Medicine for work in bacterial genetics; born in Montclair Ronald T.
Juniper is an online weight-management company operated by Eucalyptus Health. It provides telehealth-based care. Its core offerings include weight management and menopause-related services. The service operates in Australia, the United Kingdom, Germany, Japan and Canada. Juniper's programs are accessed through an online intake and clinician-led consultation. The program is combined with lifestyle support (referred to as health coaching), and may include prescription treatment with glucagon-like peptide-1 (GLP-1) receptor agonist medications, such as semaglutide (sold as Wegovy or Ozempic) and tirzepatide (Mounjaro), where clinically appropriate and allowed by local laws.
=== Birth control === A progesterone vaginal ring is available for birth control when breastfeeding in a number of areas of the world. An intrauterine device containing progesterone has also been marketed under the brand name Progestasert for birth control, including previously in the United States.
After graduating with a degree in theater from Towson University in 2003 and moving to New York City, Schumer portrayed a young woman diagnosed with breast cancer in the Off-Off-Broadway black comedy Keeping Abreast. She started doing stand-up comedy on June 1, 2004, when she first performed at Gotham Comedy Club. A few years later, she and Kevin Kane co-founded The Collective, which is a theater group that publishes and performs socially relevant and accessible work. In 2007, Schumer recorded a Live at Gotham episode for Comedy Central before appearing on Last Comic Standing; she later recalled that she thought of the episode as her "big break". Rebounding from an unsuccessful audition for an earlier season, she advanced to the finals of the fifth season of the NBC reality television talent show Last Comic Standing and placed fourth. Schumer said in April 2011, "Last Comic was totally fun. I had a great time because there was no pressure on me; I had been doing stand-up around two years. I wasn't supposed to do well. So every time I advanced it was a happy surprise. I kept it honest on the show and it served me well." Schumer co-starred in the Comedy Central reality show Reality Bites Back in 2008. In 2009, she appeared in an advertising campaign for Butterfinger. Schumer was a recurring guest on Fox News late-night program Red Eye w/ Greg Gutfeld between 2007 and 2012. Her first Comedy Central Presents special aired on April 2, 2010. She served as a co-host of A Different Spin with Mark Hoppus in 2011, later titled Hoppus on Music. She has also written for Cosmopolitan.
Sources: en.wikipedia.org
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.
Reversed-phase HPLC and mass spectrometry are standard checks. They confirm peptide purity and molecular mass, but they do not by themselves demonstrate biological activity.
Synthesis, purification, and handling conditions can differ, leading to variations in purity and salt content. Certificates of analysis help, but independent testing is often needed for verification.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.